Shanjana Awasthi, Ph.D.

Summary
Research in my lab is focused on developing immunotherapeutics and vaccines by harnessing our body's natural host defense mechanisms. Our research efforts have been focused on developing TLR4-interacting surfactant protein-A-derived peptides and dendritic cell-based vaccine approaches. We are interested in investigating the mechanisms of action and efficacy of these approaches using structural, computational, physicochemical, and immunological tools and methods, and in vitro and in animal models of infection, inflammation and cancer.
Certifications & Licenses
Categorical certificate in Clinical Microbiology
UTHSCSA, TX
2006Publications & Presentations
- 36. Vilekar P, Awasthi S, Natarajan A, Anant S, Awasthi V. EF24 suppresses maturation and inflammatory response in dendritic cells. International immunology. 2012; 24 : 455-64
37. Chandrakesan P, Ahmed I, Chinthalapally A, Singh P, Awasthi S, Anant S, Umar S. Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection. Infection and immunity. 2012; 80 : 753-67
38. Awasthi S, Singh B, Welliver R C, Dietert R R. Lung dendritic cell developmental programming, environmental stimuli, and asthma in early periods of life. Journal of allergy. 2012; 2012 : 176468
39. Moriasi C M, Trevino C, Subramaniam D, Ramalingam S, Awasthi V, Awasthi S, Anant S. Curcumin regulates Interleukin-6 expression in colon cancer cells. CANCER RESEARCH. 2011; 71
40. Awasthi S, Brown K, King C, Awasthi V, Bondugula R. A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells. The Journal of pharmacology and experimental therapeutics. 2011; 336 : 672-81
Grants
- 1. Surfactant protein-A regions as TLR4-immunomodulators. NIH. Start Date: 2017. End Date: 2023.
2. Molecular mechanism of action of TLR4-interacting SPA4 peptide in lung epithelial cell systems. Non-federal. Start Date: 2021. End Date: 2022.
3. Immunomodulation by a TLR4-interacting Surfactant protein-A peptide. Non-federal. Start Date: 2013. End Date: 2021.
4. Control of lung inflammation by a TLR4-interacting SP-A-derived peptide. NIH. Start Date: 2013. End Date: 2017.
5. Structure-function relation of a TLR4-interacting Surfactant protein-A-derived peptide. NIH. Start Date: 2013. End Date: 2014.
Awards and Honors
- 1. OUHSC. Inductee, Oklahoma Center for Mentoring Excellence, Educators for Excellence. Date: 2024.
2. University of Oklahoma Health Sciences Center. Presbyterian Health Foundation Presidential Professorship. Date: 2024.
3. NIH, DOD. Received appreciation for serving on review panels. Date: 2024.
4. University of Oklahoma Health Sciences Center. Presbyterian Health Foundation Presidential Professorship. Date: 2023.
5. University of Oklahoma Health Sciences Center. Member of Educators for Excellence. Date: 2022.
Education
- 1. Degree: Post-Baccalaureate Categorical certificate in Clinical Microbiology. University of Texas Health Sciences Center at San Antonio. Date: 2006.
2. Degree: Ph D. Sanjay Gandhi Post Graduate Institute of Medical Sciences. Date: 1995.
3. Degree: MS. Indian Institute of Technology (IIT). Date: 1990.
4. Degree: BS. MKP College, HNM Garhwal University. Date: 1988.
Administrative Assignments
no results
External Connections and Partnerships
- 1. Type: Funding. Org: Oklahoma State University (year 2013- year 2017). City: Stillwater. State: Oklahoma. NIH-supported COBRE program in Respiratory and Infectious Diseases. Date: 2013.
2. Type: Funding. Org: University of Oklahoma (year 2013- year 2014). City: Norman. State: Oklahoma. NIH-supported COBRE program in Structural Biology. Date: 2013.